Form 4 for RLMD RELMADA THERAPEUTICS, INC.
Accepted 2025-05-20 00:00:00 ET · period of report 2025-05-16 · accession 0001213900-25-046087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-05-20 | 2025-05-16+ | RLMD | Shenouda Maged | CFO | P - Purchase | $0.4865 | +200.0K | 288.3K | +226% | +$97.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-16 | P | A | 50,000 | $0.44 | 138,335 | D | — | — | (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F2) Purchase prices range from $0.4229 to $0.4674 per share, inclusive. |
| 2 | Common | Common Stock | 2025-05-19 | P | A | 90,000 | $0.49 | 228,335 | D | — | — | (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F3) Purchase prices range from $0.4493 to $0.4998 per share, inclusive. |
| 3 | Common | Common Stock | 2025-05-20 | P | A | 60,000 | $0.52 | 288,335 | D | — | — | (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F4) Purchase prices range from $0.4998 to $0.5396 per share, inclusive. |